Fetal and neonatal consequences of antenatal exposure to type 1 angiotensin II receptor-antagonists.

Détails

ID Serval
serval:BIB_D19511222818
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Titre
Fetal and neonatal consequences of antenatal exposure to type 1 angiotensin II receptor-antagonists.
Périodique
Journal of Maternal-fetal and Neonatal Medicine
Auteur(s)
Vendemmia M., Garcia-Méric P., Rizzotti A., Boubred F., Lacroze V., Liprandi A., Simeoni U.
ISSN
1476-7058 (Print)
ISSN-L
1476-4954
Statut éditorial
Publié
Date de publication
2005
Peer-reviewed
Oui
Volume
18
Numéro
2
Pages
137-140
Langue
anglais
Notes
Publication types: Case Reports ; Journal Article, pdf : Case Report
Résumé
Sartans are selective type 1 angiotensin II receptor-antagonists that are used in the treatment of arterial hypertension. Few reports are available concerning the use of sartans during pregnancy. We report two cases of adverse fetal outcome in hypertensive pregnancies exposed to sartans. In the first case, anamnios and fetal renal failure due to severe tubular dysgenesia led to termination of pregnancy in the 27th week. The second patient presented with hypocalvaria and developed fetal renal failure. The use of sartans during the two last trimesters of pregnancy should be strictly avoided.
Mots-clé
Abnormalities, Multiple/chemically induced, Abnormalities, Multiple/diagnosis, Adult, Angiotensin II/antagonists & inhibitors, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Diagnosis, Differential, Female, Humans, Hypertension/drug therapy, Infant, Newborn, Male, Pregnancy, Pregnancy Complications, Cardiovascular/drug therapy
Pubmed
Web of science
Création de la notice
22/02/2015 12:03
Dernière modification de la notice
20/08/2019 15:51
Données d'usage